Lack of direct effects of acyl ghrelin, des-acyl ghrelin, and obestatin on rat lower esophageal sphincter motility in vitro

Journal of the Chinese Medical Association

Volumn 74, Issue 9, 2011, Pages 394-399

  Chen, Chih Yen ^a,b   Huang, Shih Che ^c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

Author keywords

Acyl ghrelin; Des acyl ghrelin; Lower esophageal sphincter; Motility; Obestatin

Indexed keywords

ACYL GHRELIN; CARBACHOL; DES ACYL GHRELIN; GHRELIN; OBESTATIN; PAPAVERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; IN VITRO STUDY; LOWER ESOPHAGEAL SPHINCTER MOTILITY; LOWER ESOPHAGUS SPHINCTER; MALE; MUSCLE; MUSCLE STRIP METHOD; NONHUMAN; RAT; STIMULATION;

ANIMALS; CARBACHOL; ESOPHAGEAL SPHINCTER, LOWER; GASTROINTESTINAL MOTILITY; GHRELIN; PAPAVERINE; RATS;

EID: 80053339023     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.08.003     Document Type: Article

References (35)

1. Chen C.Y., Fujimiya M., Asakawa A., Chang F.Y., Cheng J.T., Lee S.D., et al. At the cutting edge: ghrelin gene products in food intake and gut motility. Neuroendocrinology 2009, 89:9-17.
2. Chen C.Y., Asakawa A., Fujimiya M., Lee S.D., Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev 2009, 61:430-481.
3. Chen C.Y., Doong M.L., Chien E.J., Luo J.C., Lu C.L., Lin H.C., et al. Intracerebroventricular ghrelin enhances non-nutrient semiliquid gastric emptying in fasted conscious rats. Gastroenterol J Taiwan 2008, 25:242-248.
4. Chen C.Y., Fujimiya M., Asakawa A., Lee S.D., Inui A. Regulation of ingestive behavior, the upper gastrointestinal motility and gastric acid secretion by ghrelin in mammals. Curr Nutr Food Sci 2008, 4:32-40.
5. Asakawa A., Inui A., Fujimiya M., Sakamaki R., Shinfuku N., Ueta Y., et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005, 54:18-24.
6. Chen C.Y., Chao Y., Chang F.Y., Chien E.J., Lee S.D., Doong M.L. Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats. Int J Mol Med 2005, 16:695-699.
7. Chen C.Y., Inui A., Asakawa A., Fujino K., Kato I., Chen C.C., et al. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 2005, 129:8-25.
8. Ataka K., Inui A., Asakawa A., Kato I., Fujimiya M. Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious rats. Am J Physiol Gastrointest Liver Physiol 2008, 294:G1210-G1218.
9. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310:996-999.
10. Edholm T., Levin F., Hellström P.M., Schmidt P.T. Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul Pept 2004, 121:25-30.
11. Fujino K., Inui A., Asakawa A., Kihara N., Fujimura M., Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 2003, 550:227-240.
12. Kitazawa T., De Smet B., Verbeke K., Depoortere I., Peeters T.L. Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro. Gut 2005, 54:1078-1084.
13. Vakil N., van Zanten S.V., Kahrilas P., Dent J., Jones R. Global consensus group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006, 101:1900-1920.
14. El-Serag H.B. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007, 5:17-26.
15. Goh K.L. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis 2007, 8:179-185.
16. Breckan R.K., Paulssen E.J., Asfeldt A.M., Mortensen L., Straume B., Florholmen J. The impact of body mass index and Helicobacter pylori infection on gastro-oesophageal reflux symptoms: a population-based study in northern Norway. Scand J Gastroenterol 2009, 44:1060-1066.
17. Pandolfino J.E., Kwiatek M.A., Kahrilas P.J. The pathophysiologic basis for epidemiologic trends in gastroesophageal reflux disease. Gastroenterol Clin North Am 2008, 37:827-843.
18. Zheng Z., Nordenstedt H., Pedersen N.L., Lagergren J., Ye W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology 2007, 132:87-95.
19. Chen C.Y., Fujimiya M., Laviano A., Chang F.Y., Lin H.C., Lee S.D. Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans. J Chin Med Assoc 2010, 73:225-229.
20. Nwokolo C.U., Freshwater D.A., O'Hare P., Randeva H.S. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003, 52:637-640.
21. Andrews P.L., Sanger G.J. Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction. Curr Opin Pharmacol 2002, 2:650-656.
22. Huang S.C. Endothelin receptors in lower esophageal sphincter circular smooth muscle. Regul Pept 2005, 127:27-35.
23. Huang S.C. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter. Regul Pept 2007, 142:37-43.
24. von Schrenck T., Moran T.H., Heinz-Erian P., Gardner J.D., Jensen R.T. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study. Am J Phys 1988, 255:G512-G521.
25. Furuta T., Shirai N., Xiao F., Takashima M., Hanai H. Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther 2002, 16:799-806.
26. Fukuchi T., Ashida K., Yamashita H., Kiyota N., Tsukamoto R., Takahashi H., et al. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer. J Gastroenterol 2005, 40:50-60.
27. Holloway R.H., Kocyan P., Dent J. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux. Dig Dis Sci 1991, 36:1034-1039.
28. Kuo P., Holloway R.H. Beyond acid suppression: new pharmacologic approaches for treatment of GERD. Curr Gastroenterol Rep 2010, 12:175-180.
29. Lehmann A. Novel treatments of GERD: focus on the lower esophageal sphincter. Eur Rev Med Pharmacol Sci 2008, 12(Suppl):103-110.
30. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002, 159:1029-1037.
31. Filigheddu N., Gnocchi V.F., Coscia M., Cappelli M., Porporato P.E., Taulli R., et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 2007, 18:986-994.
32. Takeshita E., Matsuura B., Dong M., Miller L.J., Matsui H., Onji M. Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract. J Gastroenterol 2006, 41:223-230.
33. Dass N.B., Munonyara M., Bassil A.K., Hervieu G.J., Osbourne S., Corcoran S., et al. Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience 2003, 120:443-453.
34. Kitazawa T., Kaiya H., Taneike T. Contractile effects of ghrelin-related peptides on the chicken gastrointestinal tract in vitro. Peptides 2007, 28:617-624.
35. Rocha-Sousa A., Falcão-Reis F., Leite-Moreira A.F. The obestatin/ghrelin system as a novel regulatory mechanism of iris muscle contraction. Curr Eye Res 2008, 33:73-79.